Inventor
SYDORENKO NADIYA
US15 patents
⚠️ This page may combine multiple inventors who share the name “SYDORENKO NADIYA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PTC THERAPEUTICS INC
14 patentsUS10874672B2Dec 29, 2020
Methods for treating Huntington's disease
PTC THERAPEUTICS INC13 citations84
US10881658B2Jan 5, 2021
Methods for treating Huntington's disease
PTC THERAPEUTICS INC2 citations71
US10428050B2Oct 1, 2019
Substituted reverse pyrimidine Bmi-1 inhibitors
PTC THERAPEUTICS INC4 citations71
US10370371B2Aug 6, 2019
Substituted pyrimidine Bmi-1 inhibitors
PTC THERAPEUTICS INC3 citations71
US11638706B2May 2, 2023
Methods for treating Huntington's disease
PTC THERAPEUTICS INC0 citations61
US11180483B2Nov 23, 2021
Substituted reverse pyrimidine Bmi-1 inhibitors
PTC THERAPEUTICS INC1 citations61
US10584115B2Mar 10, 2020
Substituted pyridine and pyrazine BMI-1 inhibitors
PTC THERAPEUTICS INC1 citations61
US12103926B2Oct 1, 2024
Compounds for treating huntington's disease
PTC THERAPEUTICS INC0 citations59
US11780839B2Oct 10, 2023
Compounds for treating Huntington's disease
PTC THERAPEUTICS INC0 citations56
US12139499B2Nov 12, 2024
Heteroaryl compounds for treating Huntington's disease
PTC THERAPEUTICS INC0 citations49
US11858941B2Jan 2, 2024
Heterocyclic and heteroaryl compounds for treating Huntington's disease
PTC THERAPEUTICS INC0 citations49
US11382918B2Jul 12, 2022
Methods for treating Huntington's Disease
PTC THERAPEUTICS INC0 citations48
US12577226B2Mar 17, 2026
Compounds for treating Huntington's disease
PTC THERAPEUTICS INC0 citations46
US9975878B2May 22, 2018
Substituted triazine BMI-1 inhibitors
PTC THERAPEUTICS INC0 citations40